American Association for Clinical Chemistry
Better health through laboratory medicine
2001 Comment Letters

Below is a listing of AACC's most recent comment letters. If you have questions regarding AACC's positions, please contact AACC Government Affairs at (800) 892-1400.

11/14/01 AACC joined with other laboratory groups in writing to Congress in support of additional funding for CDC to combat bioterrorism
   
11/08/01 AACC submitted comments to AHRQ regarding its Evidence-Based Practice Centers Program
   
10/11/01 AACC wrote to the House and Senate in support of Medicare Reform legislation
   
08/20/01 AACC wrote to all House and Senate members urging them to cosponsor the Medicare Patient Access to Preventive and Diagnostic Tests Act of 2001
   
08/16/01 AACC submits comments to CMS regarding appropriate payment rates for new clinical laboratory tests (Excel table with comments and rationale)
   
06/14/01 AACC testifies before the FDA Blood Products Panel regarding a proposal to waive Rapid HIV Testing
   
05/30/01 AACC submits comments to the FDA on its new CLIA waiver guidance document
   
05/16/01 An AACC initiated coalition writes to HHS Secretary Tommy Thompson urging the agency to reconsider the FDA's involvement in genetic testing
   
03/30/01 AACC wrote to Rep. Vernon Ehlers (R-MI) endorsing H.R.100, the National Science Education Act.
   
03/15/01 AACC wrote to Rep. Jennifer Dunn (R-WA) requesting her support for legislation reforming the Medicare payment process.
 
02/28/01 AACC wrote to Senate Edward Kennedy (D-MA) endorsing, S.710, the Eliminate Colorectal Cancer Act of 2001.
 
01/31/01 AACC provides comments to SACGT regardings its proposed template of essential information for health care professionals ordering genetic tests.
 
01/25/01 AACC provides comments to SACGT regarding its proposed testing methodology for regulating genetic testing.